Disease | severe combined immunodeficiency |
Comorbidity | C0032131|plasmacytoma |
Sentences | 1 |
PubMedID- 20560971 | In non-obese diabetic/severe combined immunodeficient mice implanted with h929 human plasmacytoma xenografts, oral treatment with enmd-2076 (50, 100, 200 mg/kg per day) resulted in a dose-dependent inhibition of tumour growth. |
Page: 1